Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.114, No.10, p.569-572, 2013 |
||
Title: Importance of systemic mediastinal lymphadenectomy in exact staging of bronchogenic carcinoma | ||
Author: V. Hytych, A. Taskova, P. Horazdovsky, Z. Konopa, R. Demes, J. Cermak, A. Vrabcova, P. Hoferka, R. Pohnan | ||
Abstract: Constituent part of radical lung resection for lung cancer is a dissection of mediastinal lymph nodes. Lymphadenectomy is a standard procedure in an assessment of clinical stage of the disease. The aim of the study was to map metastasizing of bronchogenic non-small cell lung carcinoma into homolateral mediastinal lymph nodes and to assess the importance of mediastinal lymphadenectomy for exact staging and survival. Methods: Study of 31patients with lung resection and systematic mediastinal lymphadenectomy operated from August 2004 to January 2007, with pre-operative stage Ia to IIb (TNM classification) – according to CT without mediastinal lymph nodes invasion and with positive histological finding after systematic mediastinal lymphadenectomy. Results: Tumors in right upper lobe metastasized in 45.5 % into group 1 nodes (stages N1–N4) and group 3 nodes (stages N7) and in 9 % into group 4 nodes (stages N8–N9). Tumors of the right middle lobe metastasized in 100 % into group 3 nodes (stage N7).Tumors of the right lower lobe metastasized in 87.5 % into group 3 nodes (N7) and in 12.5 % into group 4 nodes (stages N8–N9). Tumors of the left upper lobe metastasized in 9.0 % in group 1 nodes (stages N1–N4), in 82 % into group 2 nodes (stages N5–N6) and in 9.0 % were found skip metastases into group 4 nodes (stages N8–N9). Tumors of the left lower lobe metastasized in 26.7 % in group 4 nodes, 46.6 % into group 3 nodes, in 20,0 % into group 2 nodes and in 6,7 % into group 1 nodes. Conclusion: Systematic mediastinal lymphadenectomy is crucial for determining the stage of the disease according to the TNM classification. Systematic lymphadenectomy is essential for the diagnosis of stage IIIa disease and setting of additional therapy that prolongs survival (Ref. 17). |
||
Keywords: systematic lymphadenectomy, bronchogenic carcinoma, additional therapy, lung cancer. | ||
Year: 2013, Volume: 114, Issue: 10 | Page From: 569, Page To: 572 | |
doi:10.4149/BLL_2013_121 |
||
|
![]() |
|